---
figid: PMC3736724__nihms500300f1
figlink: /pmc/articles/PMC3736724/figure/F1/
number: F1
caption: Tyrosine kinase (TYK) targeting growth factor and proliferation pathways.
  Regulation of endothelial cell functions (migration, proliferation, vascular permeability,
  remodeling) is determined by the activity of protein kinases on the endothelium.
  Growth factor, angiogenesis/proliferation, and integrin pathways lead to a chain
  of events that ultimately produce changes in vascular permeability or remodeling.
  Thus, modulation with therapeutic agents such as statins and sorafenib corresponds
  to protein tyrosine kinase (PTK), which inhibits the RAS/RAF-1/MAPK pathway, and
  vascular endothelium growth factor receptor-2 (VEGFR-2) (KDR) blocker prevents vascular
  remodeling and proliferation. Statins have also been shown to modulate integrin
  signaling and VEFGR pathways to ultimately affect vascular function
pmcid: PMC3736724
papertitle: Receptor Tyrosine Kinase Inhibitors in Rodent Pulmonary Hypertension.
reftext: Liliana Moreno-Vinasco, et al. Adv Exp Med Biol. ;661:419-434.
pmc_ranked_result_index: '111329'
pathway_score: 0.9395938
filename: nihms500300f1.jpg
figtitle: Tyrosine kinase (TYK) targeting growth factor and proliferation pathways
year: ''
organisms:
- Homo sapiens
ndex: 5f546b69-df05-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3736724__nihms500300f1.html
  '@type': Dataset
  description: Tyrosine kinase (TYK) targeting growth factor and proliferation pathways.
    Regulation of endothelial cell functions (migration, proliferation, vascular permeability,
    remodeling) is determined by the activity of protein kinases on the endothelium.
    Growth factor, angiogenesis/proliferation, and integrin pathways lead to a chain
    of events that ultimately produce changes in vascular permeability or remodeling.
    Thus, modulation with therapeutic agents such as statins and sorafenib corresponds
    to protein tyrosine kinase (PTK), which inhibits the RAS/RAF-1/MAPK pathway, and
    vascular endothelium growth factor receptor-2 (VEGFR-2) (KDR) blocker prevents
    vascular remodeling and proliferation. Statins have also been shown to modulate
    integrin signaling and VEFGR pathways to ultimately affect vascular function
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR3
  - VEGFC
  - FGFR2
  - FGF2
  - FGFRL1
  - VEGFB
  - PIK3R3
  - FGFR1
  - PIK3CA
  - PLCG1
  - PGF
  - MAPK3
  - MAPK8
  - VEGFA
  - FGFR4
  - PIK3CG
  - PLCG2
  - PIK3R4
  - VEGFD
  - MAPK1
  - PIGF
  - MAPK11
  - PIK3CB
  - NRAS
  - SOS1
  - CSK
  - RAF1
  - KDR
  - PIK3R5
  - NOS3
  - MAPK14
  - MAPK9
  - MAPK10
  - PIK3CD
  - AKT2
  - AKT1
  - PIK3R6
  - CRK
  - HRAS
  - FLT1
  - ITGAV
  - NRP1
  - NFKB1
  - KRAS
  - MAP2K1
  - MAPK12
  - AKT3
  - MAPK13
  - Nitric Oxide
  - Cancer
  - Noonan syndrome
genes:
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: VEGFB
  symbol: VEGFB
  source: hgnc_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PLCG
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PLCG
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK-1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PIGF
  symbol: PIGF
  source: hgnc_symbol
  hgnc_symbol: PIGF
  entrez: '5281'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: sos-1
  symbol: SOS1
  source: hgnc_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: CSK
  symbol: CSK
  source: hgnc_symbol
  hgnc_symbol: CSK
  entrez: '1445'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: KDR
  symbol: KDR
  source: hgnc_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: NOS3
  symbol: NOS3
  source: hgnc_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: CRK
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: FLT1
  symbol: FLT1
  source: hgnc_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: ITGAV
  symbol: ITGAV
  source: hgnc_symbol
  hgnc_symbol: ITGAV
  entrez: '3685'
- word: NRP1
  symbol: NRP1
  source: hgnc_symbol
  hgnc_symbol: NRP1
  entrez: '8829'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK-1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
chemicals:
- word: Nitric Oxide
  source: MESH
  identifier: D009569
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3736724__F1
redirect_from: /figures/PMC3736724__F1
figtype: Figure
---
